Angiolutions strengthens intellectual property protection
Angiolutions strengthens intellectual property protection for its early aortic aneurysm treatment: second US patent granted Second US patent granted in
Angiolutions strengthens intellectual property protection for its early aortic aneurysm treatment: second US patent granted Second US patent granted in
Angiolutions announces advisory board to accelerate early-stage treatment for abdominal aortic aneurysms Composed of leading experts from medicine, research &
Angiolutions wins START HEALTHCARE competition ShareThis Share this on: June 18, 2024 – Angiolutions won first place in the competition
Angiolutions secures €2.5 million European Innovation Council grant to fast-track its groundbreaking aneurysm treatment Angiolutions awarded Accelerator Grant from the
Angiolutions wins 1st Place in FICPI World IP Day Competition 2023 Angiolutions’ outstanding IP strategy recognizedDr. Isabel N. Schellinger honored
Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles
June 18, 2024 – Angiolutions won first place in the competition START HEALTHCARE which was held at the MedtecLIVE Tradefair in Stuttgart.
July 27th, 2023, Angiolutions has been awarded the prestigious European Innovation Council (EIC) Accelerator Grant and will receive €2.5 million in funding for its groundbreaking treatment for early-stage abdominal aortic aneurysms.
December 10, 2022: Angiolutions has been honored with the Maxis CSI Innovator Award, acknowledging the company’s groundbreaking technology, remarkable potential for impact, robust IP strategy, and exceptional market potential in addressing abdominal aortic aneurysms.
As of December 22, 2021, Angiolutions is ISO 13485 certified. This ensures highest levels of quality and patient safety in our journey to bring the first device to treat small abdominal aortic aneurysms (AAAs) to market and to help hundred thousands of patients.
receive update emails a few times a year
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Please leave your message here